192 results
Page 2 of 10
8-K
EX-2.1
ti1zqb2spnh2gr4ey3eg
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K
t4dxpkrvzdfn9cu 2n7
11 Dec 23
Departure of Directors or Certain Officers
4:13pm
8-K
tevky0a8tap nue
7 Dec 23
Departure of Directors or Certain Officers
5:16pm
8-K
EX-99.1
05cpz
6 Nov 23
Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights
4:31pm
8-K/A
EX-99.2
8m145 ylkt
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
8-K/A
EX-99.1
ztxckr6 e8v9xusvm
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
424B5
zw4u2pyxlf2l8 hd7ibn
12 Sep 23
Prospectus supplement for primary offering
6:04am
8-K
EX-99.1
16d07v01 3v
8 Sep 23
Coherus Completes Surface Oncology Acquisition
9:12am
8-K
71jstse
8 Sep 23
Coherus Completes Surface Oncology Acquisition
9:12am
8-K
EX-99.1
vdg6pzl
2 Aug 23
Coherus BioSciences Reports Second Quarter 2023 Financial Results and Business Highlights
4:05pm
424B3
n0ox8b4wc20
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
se4cdo1lfr
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
8-K
adcl61u s5s3
20 Jul 23
Departure of Directors or Certain Officers
5:01pm
S-4
bd9s0 b75hve6
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
mm1qzasecb6jql 4l
16 Jun 23
Business combination disclosure
8:08am
425
922 pxemzfv6fwdl
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-2.1
arul763y 1q8twz
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am